← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Isoprene Pharmaceuticals, Inc.
Baltimore, MD
$3,012,722
Total funding
2
Grants
Funding over time
peak $1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,012,722 · 2
By mechanism
R44$3,012,722 · 2
Investigators at Isoprene Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer$1,022,522
R44 · FY2025 · CA
Development of VNLG-152R as novel therapeutic for triple negative breast cancer$995,100
R44 · FY2022 · CA
Development of VNLG-152R as novel therapeutic for triple negative breast cancer$995,100
R44 · FY2021 · CA